Search Results - Joshua Armenia

Refine Results
  1. 1
    A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance

    A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance by Luis Tobalina, Joshua Armenia, Elsa Irving, Mark J. O’Connor, Josep V. Forment

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Impact of DNA damage repair alterations on prostate cancer progression and metastasis

    Impact of DNA damage repair alterations on prostate cancer progression and metastasis by Natalia Lukashchuk, Alan Barnicle, Carrie A. Adelman, Joshua Armenia, Jinyu Kang, J. Carl Barrett, Elizabeth A. Harrington

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Cancer-driving mutations are enriched in genic regions intolerant to germline variation

    Cancer-driving mutations are enriched in genic regions intolerant to germline variation by Dimitrios Vitsios, Ryan S. Dhindsa, Dorota Matelska, Jonathan Mitchell, Xuequing Zou, Joshua Armenia, Fengyuan Hu, Quanli Wang, Ben S. Sidders, Andrew R. Harper, Slavé Petrovski

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    p27 <sup>kip1</sup> controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability

    p27 <sup>kip1</sup> controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability by Linda Fabris, Stefania Berton, Ilenia Pellizzari, Ilenia Segatto, Sara D’Andrea, Joshua Armenia, Riccardo Bomben, Mónica Schiappacassi, Valter Gattei, Mark R. Philips, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer

    Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer by Tong Sun, Shin-Yi Du, Joshua Armenia, Fangfang Qu, Jing‐Yu Fan, Xiaodong Wang, Fei Teng, Kazumasa Komura, Shirley X. Liu, Gwo‐Shu Mary Lee, Philip W. Kantoff

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy

    Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy by R. Kim, Minsuk Kwon, Minae An, S.T. Kim, Simon A. Smith, Arsène‐Bienvenu Loembé, Peter G. Mortimer, Joshua Armenia, Natalia Lukashchuk, N. Shah, Emma Dean, W.-Y. Park, J. Lee

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Unifying cancer and normal RNA sequencing data from different sources

    Unifying cancer and normal RNA sequencing data from different sources by Qingguo Wang, Joshua Armenia, Chao Zhang, Alexander Penson, Ed Reznik, Liguo Zhang, Thais Minet, Angelica Ochoa, Benjamin Groß, Christine A. Iacobuzio‐Donahue, Doron Betel, Barry S. Taylor, Jianjiong Gao, Nikolaus Schultz

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer

    Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer by Neel Shah, Ping Wang, John Wongvipat, Wouter R. Karthaus, Wassim Abida, Joshua Armenia, Shira Rockowitz, Yotam Drier, B Bernstein, Henry W. Long, Matthew L. Freedman, Vivek Arora, Deyou Zheng, Charles L. Sawyers

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation

    CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation by Alessandra Dall’Acqua, Maura Sonego, Ilenia Pellizzari, Ilenia Pellarin, Vincenzo Canzonieri, Sara D’Andrea, Sara Benevol, Roberto Sorio, Giorgio Giorda, Daniela Califano, Marina Bagnoli, Loredana Militello, Delia Mezzanzanica, Gennaro Chiappetta, Joshua Armenia, Barbara Belletti, Mónica Schiappacassi, Gustavo Baldassarre

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis

    ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis by Rohit Bose, Wouter R. Karthaus, Joshua Armenia, Wassim Abida, Phillip J. Iaquinta, Zeda Zhang, John Wongvipat, Elizabeth V. Wasmuth, Neel Shah, Patrick Sullivan, Michael G. Doran, Ping Wang, Anna Patruno, Yilin Zhao, Deyou Zheng, Nikolaus Schultz, Charles L. Sawyers

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    SLFN11 informs on standard of care and novel treatments in a wide range of cancer models

    SLFN11 informs on standard of care and novel treatments in a wide range of cancer models by C Winkler, Joshua Armenia, Gemma N. Jones, Luis Tobalina, Matthew J. Sale, Tudor Petreuş, Tarrion Baird, Violeta Serra, Anderson T. Wang, Alan Lau, Mathew J. Garnett, Patricia Jaaks, Elizabeth A. Coker, Andrew J. Pierce, Mark J. O’Connor, Elisabetta Leo

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

    Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate by Habiba Elfandy, Joshua Armenia, Filippo Pederzoli, Eli Pullman, Nelma Pértega‐Gomes, Nikolaus Schultz, Kartik Viswanathan, Aram Vosoughi, Mirjam Blattner, Konrad H. Stopsack, Giorgia Zadra, Kathryn L. Penney, Juan Miguel Mosquera, Svitlana Tyekucheva, Lorelei A. Mucci, Christopher E. Barbieri, Massimo Loda

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway

    Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway by Linda Fabris, Stefania Berton, Francesca Citron, Sara D’Andrea, Ilenia Segatto, Milena S. Nicoloso, Samuele Massarut, Joshua Armenia, Gaetano Zafarana, Simona Rossi, Cristina Ivan, Tiziana Perin, Jayant S. Vaidya, Michele Avanzo, Mario Roncadin, Mónica Schiappacassi, Robert G. Bristow, George A. Călin, Gustavo Baldassarre, Barbara Belletti

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression

    Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression by Goutam Chakraborty, Joshua Armenia, Ying Z. Mazzu, Subhiksha Nandakumar, Konrad H. Stopsack, Mohammad Atiq, Kazumasa Komura, Lina Jehane, Rahim Hirani, Kalyani Chadalavada, Yuki Yoshikawa, Nabeela Khan, Yu Chen, Wassim Abida, Lorelei A. Mucci, Gwo‐Shu Mary Lee, Gouri J. Nanjangud, Philip W. Kantoff

    Published 2019
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  15. 15
    PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors

    PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors by Anna D. Staniszewska, Joshua Armenia, Matthew King, Chrysiis Michaloglou, Avinash Reddy, Maneesh Singh, Maryann San Martin, Laura B. Prickett, Zena Wilson, Theresa A. Proia, Deanna L. Russell, Morgan Thomas, Oona Delpuech, Mark J. O’Connor, Elisabetta Leo, Helen K. Angell, Viia Valge-Archer

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma

    An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma by Francesca Citron, Joshua Armenia, Giovanni Franchin, Jerry Polesel, Renato Talamini, Sara D’Andrea, Sandro Sulfaro, Carlo M. Croce, William Klement, David Otasek, Chiara Pastrello, Tomáš Tokár, Igor Jurišica, Deborah French, Riccardo Bomben, Emanuela Vaccher, Diego Serraino, Barbara Belletti, Andrea Vecchione, Luigi Barzan, Gustavo Baldassarre

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer

    Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer by Martin G. Dalin, Alexis Desrichard, Nora Katabi, Vladimir Makarov, Logan A. Walsh, Ken-Wing Lee, Qingguo Wang, Joshua Armenia, Lyndsay West, Snjezana Doğan, Lu Wang, Deepa Ramaswami, Alan L. Ho, Ian Ganly, David B. Solit, Michael F. Berger, Nikolaus Schultz, Jorge S. Reis‐Filho, Timothy A. Chan, Luc G.T. Morris

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Genome doubling shapes the evolution and prognosis of advanced cancers

    Genome doubling shapes the evolution and prognosis of advanced cancers by Craig M. Bielski, Ahmet Zehir, Alexander Penson, Mark T.A. Donoghue, Walid K. Chatila, Joshua Armenia, Matthew T. Chang, Alison M. Schram, Philip Jonsson, Chaitanya Bandlamudi, Pedram Razavi, Gopa Iyer, Mark E. Robson, Zsofia K. Stadler, Nikolaus Schultz, José Baselga, David B. Solit, David M. Hyman, Michael F. Berger, Barry S. Taylor

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D

    ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D by Kazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, Goutam Chakraborty, Travis Gerke, Kunihiko Hinohara, Kalyani Chadalavada, Seong Ho Jeong, Joshua Armenia, Shin-Yi Du, Ying Z. Mazzu, Kohei Taniguchi, Naokazu Ibuki, Clifford A. Meyer, Gouri J. Nanjangud, Teruo Inamoto, Gwo‐Shu Mary Lee, Lorelei A. Mucci, Haruhito Azuma, Christopher J. Sweeney, Philip W. Kantoff

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)

    A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2) by Ying Z. Mazzu, Joshua Armenia, Goutam Chakraborty, Yuki Yoshikawa, Si’Ana A. Coggins, Subhiksha Nandakumar, Travis Gerke, Mark M. Pomerantz, Xintao Qiu, HuiYong Zhao, Mohammad Atiq, Nabeela Khan, Kazumasa Komura, Gwo‐Shu Mary Lee, Samson W. Fine, Connor Bell, Edward O’Connor, Henry W. Long, Matthew L. Freedman, Baek Kim, Philip W. Kantoff

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: